– Companies to collaborate on advancement of a novel small-molecule therapeutic for Duchenne muscular dystrophy – January 08, 2016 07:00 AM Eastern Standard Time CAMBRIDGE, Mass. & AACHEN, […]
FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company is stopping its Phase 2 clinical study of the investigational monoclonal antibody simtuzumab among patients with idiopathic pulmonary […]
